Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL

被引:14
作者
Caterer, Nigel R.
Graversen, Jonas H.
Jacobsen, Christian
Moestrup, Soren K.
Sigurskjold, Bent W.
Etzerodt, Michael
Thogersen, Hans C. [1 ]
机构
[1] Univ Aarhus, Dept Biol Mol & Struct, Gene Express Lab, DK-8000 Aarhus C, Denmark
[2] Univ Aarhus, Dept Biochem Med, DK-8000 Aarhus C, Denmark
[3] Univ Copenhagen, August Krogh Inst, DK-2200 Copenhagen, Denmark
关键词
binding site grafting; CTLD; Lys binding;
D O I
10.1515/BC.2002.195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Lipoprotein(a) is composed of low density lipoprotein and apolipoprotein(a). Apolipoprotein(a) has evolved from plasminogen and contains 10 different plasminogen kringle 4 homologous domains [KIV(1 - 110)]. Previous studies indicated that lipoprotein(a) non-covalently binds the N-terminal region of lipoprotein B100 and the plasminogen kringle 4 binding plasma protein tetranectin. In this study recombinant KIV(2), KIV(7) and KIV(10) derived from apolipoprotein(a) were produced in E. coli and the binding to tetranectin and low density lipoprotein was examined. Only KIV(10) bound to tetranectin and binding was similar to that of plasminogen kringle 4 to tetranectin. Only KIV(7) bound to LDL. In order to identify the residues responsible for the difference in specificity between KIV(7) and KIV(10), a number of surface-exposed residues located around the lysine binding clefts were exchanged. Ligand binding analysis of these derivatives showed that Y62, and to a minor extent W32 and E56, of KIV(7) are important for LDL binding to KIV(7), whereas R32 and D56 of KIV(10) are required for tetranectin binding of KIV(10).
引用
收藏
页码:1743 / 1750
页数:8
相关论文
共 41 条
[1]
BERG K, 1974, CLIN GENET, V6, P230
[2]
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study [J].
Bostom, AG ;
Cupples, LA ;
Jenner, JL ;
Ordovas, JM ;
Seman, LJ ;
Wilson, PWF ;
Schaefer, EJ ;
Castelli, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :544-548
[3]
PLASMA-LIPOPROTEINS - TEACHING OLD DOGMAS NEW TRICKS [J].
BROWN, MS ;
GOLDSTEIN, JL .
NATURE, 1987, 330 (6144) :113-114
[4]
SITE-SPECIFIC MUTAGENESIS DEMONSTRATES THAT CYSTEINE-4326 OF APOLIPOPROTEIN-B IS REQUIRED FOR COVALENT LINKAGE WITH APOLIPOPROTEIN(A) IN-VIVO [J].
CALLOW, MJ ;
RUBIN, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :23914-23917
[6]
PURIFICATION AND CHARACTERIZATION OF A NOVEL, OLIGOMERIC, PLASMINOGEN KRINGLE 4 BINDING-PROTEIN FROM HUMAN PLASMA-TETRANECTIN [J].
CLEMMENSEN, I ;
PETERSEN, LC ;
KLUFT, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 156 (02) :327-333
[7]
Ten-year follow-up results from the Goettingen risk, incidence and prevalence study (GRIPS) .1. Risk factors for myocardial infarction in a cohort of 5790 men [J].
Cremer, P ;
Nagel, D ;
Mann, H ;
Labrot, B ;
MullerBerninger, R ;
Elster, H ;
Seidel, D .
ATHEROSCLEROSIS, 1997, 129 (02) :221-230
[8]
LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[9]
Dissection of the domain architecture of the alpha(2)macroglobulin-receptor-associated protein [J].
Ellgaard, L ;
Holtet, TL ;
Nielsen, PR ;
Etzerodt, M ;
Gliemann, J ;
Thogersen, HC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02) :544-551
[10]
The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a) [J].
Frank, S ;
Kostner, GM .
PROTEIN ENGINEERING, 1997, 10 (03) :291-298